Luisa Amoedo Otero is a biotechnology industry executive with over 22 years of experience in GMP/GLP pharmaceutical manufacturing, with a career built around launching and scaling biomanufacturing operations for the global life sciences sector. She currently serves as VP of Operations at Recipharm Advance Bio, overseeing operations, supply chain, engineering, and procurement across manufacturing sites in the United States, Germany, and Portugal. Previously, she led the design, construction, and startup of Viralgen's biotechnology plant in San Sebastián, a facility supporting viral vector and gene therapy production, and served as Lab Operation Head across Sartorius CMTS sites in Ulm, Glasgow, and Cambridge (Boston) — steering operations through the COVID-19 crisis while delivering significant gains in productivity and sales capacity. Earlier in her career, she led the construction and startup of the mAbxience biotechnology plant in León, achieving regulatory approval from the EMA, ANMAT, and health authorities in Mexico, Saudi Arabia, and Turkey, and spent nearly a decade at Lonza Biologics implementing biotechnology manufacturing processes across multiple customer programs and international regulatory audits. A chemist by training (University of Santiago de Compostela) with an MBA and postgraduate training in operational excellence (Lean/Six Sigma), Luisa is recognized for her ability to build multidisciplinary teams and translate complex regulatory and manufacturing requirements into operational results. She was named Best Export and Internationalization Executive (Castilla y León Económica, 2018) and Best Executive/Entrepreneur of the Year (ASELE/FELE, 2022).